Skip to main content
Equibles
QSI logo

QSI · Quantum-Si Inc · Metrics

Track QSI — free

Use QSI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research QSI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.17 +0.08 (+7.34%)
Rebalance outlook locked
Market Cap
$238.58M
Shares
218.88M
Volume · Oct 20 6.16M Avg daily vol (3M) 5.27M

QSI metrics

75 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.16
Market cap
$238.58M

Price action

20 metrics
Price change (1W)
-19.9%
Price change (30D)
+44.2%
Price change (3M)
+33.4%
Price change (6M)
+7.9%
Price change (YTD)
-0.9%
Price change (1Y)
-52.2%
Trailing year
Price change (5Y)
-87.2%
52-week high
$2.59
52-week low
$0.70
Change from 52-week high
-57.8%
Change from 52-week low
+55.2%
Annualized volatility
95.8%
Annualized volatility (3M)
124.9%
Beta
3.4
RSI (14D)
49.0
Price vs SMA 50
+17.8%
Price vs SMA 200
+14.3%
Avg volume (3M)
5.20M
Relative volume
1.7
Average dollar volume
$5.87M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
218.88M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
152.7×
reciprocal yield 0.7%
P / book
1.4
reciprocal yield 73.5%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-40.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
35.0%
Operating margin
-6,887.8%
Trailing 12 months
Net margin
-6,138.3%
Gross profit (TTM)
$562,000
Operating profit (TTM)
−$110.55M
Net income (TTM)
−$98.52M
Trailing 12 months
Diluted EPS (TTM)
$-0.45
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.01
Gross profit per diluted share (TTM)
$0.00
Operating profit per diluted share (TTM)
$-0.52
EBITDA per diluted share (TTM)
$-0.49
Net income per diluted share (TTM)
$-0.46
Operating cash flow per diluted share (TTM)
$-0.43
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.26
Stock compensation per diluted share (TTM)
$0.05
Book value per share
—

Growth

11 metrics
Revenue growth YoY
-41.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.60M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+18.6%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-54.7%
Return on assets
-50.9%
Debt / equity
—
Current ratio
10.0
EBITDA (TTM)
−$105.79M
Free cash flow (TTM)
—
Quick ratio
9.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$23.65M
Latest balance sheet
Cash & equivalents
$23.65M
Total assets
$193.57M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$92.45M
Capital expenditures (TTM)
$1.24M
R&D (TTM)
$55.14M
SG&A (TTM)
$40.59M
Stock compensation (TTM)
$11.13M
R&D / revenue
3,435.5%
Stock compensation / revenue
693.5%

Ownership (13F)

9 metrics
13F filers
141
13F filer change QoQ
-17
Institutional ownership
24.6%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+15.6%
Holder tenure
11.7
Price vs estimated holder cost
-71.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
7.2%

Short interest

3 metrics
Short interest
5.4%
Latest settlement · 2.5 days to cover
Days to cover
2.5d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$39,411
Insider-sentiment score
37 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1816431 CUSIP 74765K105 13F (30d) 11 filings 11 filers Visit website Investor relations